News
🇪🇺 EMA Page 27Latest pharmaceutical news, drug approvals, and EMA regulatory updates
Showing 313–324 of 341 articles
MENA Medical Device Regulatory Training Course Launches May 2026 to Address Growing Market Demand
2 min
Prof. Marcus WebbCMO/CDMO Market to Reach $5.46 Billion by 2035 as Biologics Manufacturing Outsourcing Accelerates
2 min
Prof. Marcus WebbNew Clinical Trial Monitoring Course Addresses Rising GCP Compliance Issues in Biopharmaceutical Industry
2 min
Prof. Marcus WebbNew GCP Inspections Training Course Addresses ICH GCP E6(R3) and EU CTR Compliance for Pharmaceutical Companies
FDA · 2 min
Prof. Marcus WebbVabysmo Market Report 2026: Roche's Eye Drug Shows Strong Growth Through 2035 Amid Rising Retinal Disorder Cases
2 min
Dr. Elena RossiGlycoNex GNX1021 Gets PMDA Approval for First-in-Human Phase 1 Trial in Gastrointestinal Cancers
PMDA · 2 min
Dr. Elena RossiEMA AI System for Faster Drug Safety Signal Detection
EMA · Pharmacovigilance · 6 min
Dr. Elena RossiEuropean Commission Blockchain Pilot Enhances Pharmaceutical Supply Chain Security
European Commission · 6 min
Dr. Elena RossiEMA Conditional Approval CAR-T Therapy for Relapsed B-Cell Lymphoma
EMA · Oncology · 4 min
Dr. Elena RossiEMA Issues Positive Opinion for Zepzelca (Lurbinectedin) in Cancer Treatment
EMA · 2 min
Dr. Elena RossiEMA Backs Amgen's Tarlatamab as First-in-Class BiTE Therapy for Advanced Small Cell Lung Cancer
EMA · oncology · 3 min
Dr. Elena RossiEMA Issues Positive Opinion for Adstiladrin Gene Therapy in Bladder Cancer Treatment
EMA · 2 min
Dr. Elena RossiPopular topics
- Drug Approvals 1,128 articles
- Clinical Trials 634 articles
- Regulatory Updates 687 articles
- Press Releases 443 articles
- Oncology 443 articles
- Mergers & Acquisitions 105 articles
- Rare Diseases 141 articles
Explore intelligence
- Global markets Cross-region command center
- Company directory Sponsor & marketer profiles
- Drug profiles INN & regulatory status
- Clinical trials hub Stage & therapy filters
- Pipeline programs R&D intelligence
- Patent landscape US & EP IP moats
- Event calendar Congress catalysts
- Regulatory reference Submission types & pathways